Claim Missing Document
Check
Articles

Found 2 Documents
Search

Effects of Cinnamon Bark Extract, Moderate Intensity Exercise, Intermittent Fasting, Metformin on Fasting Blood Glucose Levels, Lipid Profile and Malondialdehyde in DMT2 Rats: Case Study Vonikartika, Arie
Journal of Health Science and Medical Therapy Том 3 № 02 (2025): Journal of Health Science and Medical Therapy
Publisher : PT. Riset Press International

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.59653/jhsmt.v3i02.1884

Abstract

Diabetes is a silent killer. Diabetes mellitus (DM) occurs when the pancreas does not produce enough insulin or the body cannot use insulin effectively. DM is often characterised by chronic hyperglycemia. Diabetes Mellitus (DM) is one of the Non-Communicable Diseases (NCDs), which is a public health problem and has a relatively high number of sufferers in the world. Many ways are used to treat and prevent DM, including changing to a healthier lifestyle and using modern medicine or herbal medicine that can improve hyperglycemia in DM patients. This study was conducted to determine the effects of cinnamon extract with a dose of 120 mg / kgBW / day orally, moderate swimming exercise, and intermittent fasting for 19 days on T2DM Rats. The study shows that there was a significant increase (p<0.005) in Fasting Blood Glucose (FBG) between day 1 and day 4 in the untreated group. In the group given metformin, there was a significant change in FBS on day 1 and day 4. In the group given cinnamon extract, there was a change in FBG on days 1 and 4 (increase) and days 10 and 13 (decrease). In the swimming group, there was an increase in FBG on day 1 and day 4 and a significant decrease in FBS on days 10 and 14, while in intermittent fasting, there was an increase in FBS on day 1 and day 4, which was statistically significant. Increases and decreases in lipid and Malondialdehyde (MDA) profiles were also present in each treatment group. The conclusion is that cinnamon bark extract, moderate-intensity swimming exercise, and intermittent fasting impact fasting blood glucose levels, lipid profiles, and MDA in Diabetes induced rats.
FORMULASI DAN UJI EVALUASI SEDIAAN SELF-NANOEMULSIFYING DRUG DELIVERY SYSTEM (SNEDDS) DARI EKSTRAK METANOL AKAR PANDAN LAUT (PANDANUS ODORIFER) Ghiffari, Habibie Deswilyaz; Suhendra, Arif; Vonikartika, Arie; Roza Erda
Jurnal Ilmiah Manuntung: Sains Farmasi Dan Kesehatan Vol. 11 No. 2 (2025): Jurnal Ilmiah Manuntung: Sains Farmasi dan Kesehatan
Publisher : Sekolah Tinggi Ilmu Kesehatan Samarinda

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.51352/jim.v11i2.964

Abstract

Background: Pandanus odorifer is a coastal plant in Southeast Asia with roots rich in bioactive compounds such as phenolics, flavonoids, saponins, and alkaloids. Limited solubility and bioavailability of lipophilic compounds hinder therapeutic effectiveness. Objective: To develop and evaluate Self-Nanoemulsifying Drug Delivery System (SNEDDS) formulation from sea pandanus root methanol extract to enhance solubility and stability. Methods: Root extraction was performed using soxhlet method with methanol solvent. Six SNEDDS formulas were developed with variations of Tween 80/Tween 20 surfactant combinations and PEG 400/propylene glycol cosurfactants. Evaluation included simplicia characterization, organoleptic tests, creaming tests, pH and viscosity measurements, centrifugation, freeze-thaw stability, solubility, and droplet size analysis. Results: Extract yield reached 7.72% with simplicia characterization meeting pharmacopoeial standards. Formula F3 (Tween 80 21.4%, PEG 400 21.4%, VCO 4.75%, extract 5%) demonstrated optimal stability with pH 6.91±0.04, viscosity 253.33±11.55 cPs, HLB value 14.50, and average droplet size 530 nm. This formula maintained homogeneity throughout all stability tests without phase separation. Conclusion: SNEDDS from Pandanus odorifer root methanol extract formula F3 possesses physicochemical characteristics and stability suitable for nanoemulsion-based drug delivery systems.